Managing relapse in multiple myeloma requires a tailored approach incorporating current therapies such as proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and emerging treatments like CAR-T therapy to extend survival and quality of life.

Refractory multiple myeloma presents significant treatment challenges. This article delves into current therapeutic strategies, including novel agents, CAR-T cell therapy, and monoclonal antibodies, aimed at improving patient outcomes.

Relapsed multiple myeloma presents significant treatment challenges. This article delves into current therapeutic strategies, including novel agents, stem cell transplantation, and emerging immunotherapies, aimed at improving patient outcomes.

Tardive Dyskinesia (TD) is a movement disorder characterized by involuntary, repetitive movements. This article delves into its association with Parkinson's Disease, highlighting causes, symptoms, and treatment strategies.

Migraines are intense, recurring headaches often accompanied by nausea and sensitivity to light. This article delves into their causes, symptoms, and effective treatment strategies.